EXTRINSIC APOPTOTIC PATHWAY (PW:0000106)
Description
Apoptosis, or programmed cell death, removes excess or damaged cells to maintain tissue homeostasis. The two major apoptotic pathways – the extrinsic, triggered by ligands activating the death receptors and the intrinsic (mitochondrial), triggered by intracellular stresses – converge on the activation of executioner caspases. The ligands and their cognate death receptors belong to the tumor necrosis factor (TNF) superfamilies of ligands and receptors. FasL, Trail and Tnf itself are the major death ligands activating the extrinsic apoptotic pathway. Note that the primary role of Tnf is pro-inflammatory and pro-growth via downstream activation of Nuclear Factor Kappa B signaling. If NF-kB is not activated, the formation of a second complex can trigger Tnf mediated apoptosis. However,
in vivo Tnf-mediated apoptosis appears to play a minor role. The receptors contain an extracellular CCG (
cysteine rich domain ) that plays a role in the interaction with ligands, and a cytoplasmic DD (
death domain ) involved in receptor-adapter interactions. Assembly of a trimeric ligand-receptor complex and subsequent receptor-adapter interactions, result in the formation of DISC (death-inducing signaling complex). Fadd, the major adapter molecule, via its second functional domain DED (
death effector domain ) recruits the initiator caspase Casp8 and when present, Casp10 to the DISC where they are activated. Note that in the case of Tnf mediated apoptosis, the receptor is indirectly linked to Fadd via Tradd. Like Fadd, Casp8 and 10 posses a DED domain. Casp9, the initiator caspase of the intrinsic apoptotic pathway possesses a CARD (
caspase recruitment domain ); of note is that the three domains DD, DED and CARD adopt a similar structural fold. The molecular mechanism of caspase activation at the DISC is not well understood; three models currently attempt to explain it. Activated Casp8 can then activate the effector/executioner caspases; this is the case of type I cells. In type II cells, amplification via the intrinsic, mitochondrial pathway is necessary for full activation of the executioner caspases. In this case, activated Casp8 cleaves Bid to the active t-Bid form. Bid is a member of the pro-apoptotic BH3-only group of the Bcl family. Cflar protein (known as Flip) can also be recruited to the DISC where it antagonizes the activation of Casp8. DED-DED interactions mediate the recruitment; the inhibition is thought to be due to competition for Fadd binding. There are several Cflar variants resulting from alternative mRNA splicing of which three are expressed at the protein level. While the anti-apoptotic effect is well documented, a pro-apoptotic function for one of the variants has been observed for the FasL system, under certain conditions. The receptors and other members of DISC are subject to several types of post-translational modifications that modulate their function. The role of lipid rafts and protein clustering in the formation of an active DISC have been documented for the FasL system. FasL and Trail can also elicit noncytotoxic signals; how these other pathways enfold is currently being investigated. The major components and steps of the extrinsic apoptotic pathways have been established but much remains to be determined regarding their fine-tuning and individual details.
...(less)
Pathway Diagram:
Genes in Pathway:
G
Casp3
caspase 3
ISO
RGD
PMID:17082813
RGD:2314187
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Casp7
caspase 7
ISO
RGD
PMID:17082813
RGD:2314187
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
G
Casp8
caspase 8
ISO
RGD
PMID:17082813
RGD:2314187
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
G
Fas
Fas cell surface death receptor
IEP
germ cells
RGD
PMID:17195944
RGD:1626509
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
G
Faslg
Fas ligand
IGI
RGD
PMID:16154149
RGD:1582433
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
G
Akt1
AKT serine/threonine kinase 1
ISO
PID
PID:200080
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:137,535,390...137,552,610
G
Bid
BH3 interacting domain death agonist
IEP ISO
PID RGD
PMID:18090083 PMID:19239902
PID:200080, RGD:2314002 , RGD:4143196
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
G
Birc2
baculoviral IAP repeat-containing 2
ISO
PID
PID:200080
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911
G
Birc3
baculoviral IAP repeat-containing 3
ISO
PID
PID:200080
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590
G
Btk
Bruton tyrosine kinase
ISO
PID
PID:200080
NCBI chr X:102,016,070...102,055,448
Ensembl chr X:102,016,074...102,055,143
G
Casp3
caspase 3
ISO
PID RGD
PMID:19239902
PID:200080, RGD:4143196
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Casp7
caspase 7
ISO
RGD
PMID:19239902
RGD:4143196
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
G
Casp8
caspase 8
IMP ISO
PID RGD
PMID:18090083 PMID:19239902
PID:200080, RGD:2314002 , RGD:4143196
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
G
Cflar
CASP8 and FADD-like apoptosis regulator
ISO IEP
PID RGD
PMID:19239902 PMID:19107989
PID:200080, RGD:4143196 , RGD:8662854
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
ISO
PID
PID:200080
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:252,908,749...252,944,273
G
Cltc
clathrin heavy chain
ISO
PID
PID:200080
NCBI chr10:72,014,984...72,073,308
Ensembl chr10:72,014,986...72,070,691
G
Ezr
ezrin
ISO
PID
PID:200080
NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:49,373,035...49,416,573
G
Fadd
Fas associated via death domain
ISO
PID RGD
PMID:19239902
PID:200080, RGD:4143196
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
G
Faim2
Fas apoptotic inhibitory molecule 2
ISO
PID
PID:200080
NCBI chr 7:132,512,095...132,539,192
Ensembl chr 7:132,512,210...132,538,026
G
Fas
Fas cell surface death receptor
IEP ISO
PID RGD
PMID:18090083 PMID:19107989 PMID:19239902
PID:200080, RGD:2314002 , RGD:8662854 , RGD:4143196
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:241,205,935...241,246,104
G
Faslg
Fas ligand
IEP ISO
PID RGD
PMID:18090083 PMID:19239902
PID:200080, RGD:2314002 , RGD:4143196
NCBI chr13:76,680,885...76,706,042
Ensembl chr13:76,688,243...76,695,503
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
ISO
PID
PID:200080
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ISO
PID
PID:200080
NCBI chr X:157,358,279...157,397,563
Ensembl chr X:157,367,639...157,392,757
G
Map2k6
mitogen-activated protein kinase kinase 6
ISO
PID
PID:200080
NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,872,546...95,987,721
G
Map2k7
mitogen activated protein kinase kinase 7
ISO
PID
PID:200080
NCBI chr12:7,389,032...7,398,377
Ensembl chr12:7,389,155...7,398,377
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
ISO
PID
PID:200080
NCBI chr 2:45,081,889...45,150,555
Ensembl chr 2:45,081,889...45,149,897
G
Mapk10
mitogen activated protein kinase 10
ISO
PID
PID:200080
NCBI chr14:6,802,247...7,094,103
Ensembl chr14:6,802,295...7,094,100
G
Mapk11
mitogen-activated protein kinase 11
ISO
PID
PID:200080
NCBI chr 7:122,098,120...122,105,023
Ensembl chr 7:122,098,121...122,105,038
G
Mapk14
mitogen activated protein kinase 14
ISO
PID
PID:200080
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,751,357...6,812,294
G
Mapk8
mitogen-activated protein kinase 8
ISO
PID
PID:200080
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
G
Mapk9
mitogen-activated protein kinase 9
ISO
PID
PID:200080
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,670,756...34,712,228
G
Pdpk1
3-phosphoinositide dependent protein kinase-1
ISO
PID
PID:200080
NCBI chr10:13,610,000...13,687,226
Ensembl chr10:13,610,063...13,679,181
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
ISO
PID
PID:200080
NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:117,143,468...117,177,411
G
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
ISO
PID
PID:200080
NCBI chr 8:108,474,017...108,579,140
Ensembl chr 8:108,474,019...108,579,331
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
ISO
PID
PID:200080
NCBI chr 5:165,377,994...165,426,620
Ensembl chr 5:165,377,994...165,403,968
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
ISO
PID
PID:200080
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347
G
Pik3r2
phosphoinositide-3-kinase regulatory subunit 2
ISO
PID
PID:200080
NCBI chr16:18,699,389...18,708,045
Ensembl chr16:18,699,448...18,709,665
G
Pik3r3
phosphoinositide-3-kinase regulatory subunit 3
ISO
PID
PID:200080
NCBI chr 5:134,936,790...135,009,303
Ensembl chr 5:134,934,857...135,007,762
G
Rfc1
replication factor C subunit 1
ISO
PID
PID:200080
NCBI chr14:43,319,768...43,395,028
Ensembl chr14:43,319,935...43,395,026
G
Ripk1
receptor interacting serine/threonine kinase 1
ISO
PID
PID:200080
NCBI chr17:31,044,983...31,077,167
Ensembl chr17:31,044,994...31,077,167
G
Smpd1
sphingomyelin phosphodiesterase 1
ISO
PID
PID:200080
NCBI chr 1:169,304,772...169,308,615
Ensembl chr 1:169,304,708...169,308,614
G
Src
SRC proto-oncogene, non-receptor tyrosine kinase
ISO
PID
PID:200080
NCBI chr 3:166,511,616...166,559,463
Ensembl chr 3:166,511,985...166,559,462
G
Syk
spleen associated tyrosine kinase
ISO
PID
PID:200080
NCBI chr17:12,756,493...12,830,927
Ensembl chr17:12,756,493...12,813,278
G
Bid
BH3 interacting domain death agonist
ISO
RGD
PMID:17403612 PMID:19961901
RGD:4143170 , RGD:4143171
NCBI chr 4:155,785,366...155,808,775
Ensembl chr 4:155,785,377...155,808,275
G
Casp3
caspase 3
ISO
RGD
PMID:17403612 PMID:19961901
RGD:4143170 , RGD:4143171
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:52,395,540...52,413,732
G
Casp7
caspase 7
ISO
RGD
PMID:19961901
RGD:4143171
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:265,442,676...265,482,512
G
Casp8
caspase 8
ISO
PID RGD
PMID:17403612 PMID:19961901
PID:200068, RGD:4143170 , RGD:4143171
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
G
Cflar
CASP8 and FADD-like apoptosis regulator
ISO
PID RGD
PMID:17403612 PMID:19961901
PID:200068, RGD:4143170 , RGD:4143171
NCBI chr 9:67,679,502...67,747,226
Ensembl chr 9:67,679,559...67,726,434
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
ISO
PID
PID:200068
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:252,908,749...252,944,273
G
Dap3
death associated protein 3
ISO
PID
PID:200068
NCBI chr 2:176,617,151...176,645,293
Ensembl chr 2:176,617,155...176,644,270
G
Fadd
Fas associated via death domain
ISO
PID RGD
PMID:17403612 PMID:19961901
PID:200068, RGD:4143170 , RGD:4143171
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
ISO
PID
PID:200068
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ISO
PID
PID:200068
NCBI chr X:157,358,279...157,397,563
Ensembl chr X:157,367,639...157,392,757
G
Map2k4
mitogen activated protein kinase kinase 4
ISO
PID
PID:200068
NCBI chr10:50,842,348...50,947,063
Ensembl chr10:50,844,034...50,947,185
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
ISO
PID
PID:200068
NCBI chr 2:45,081,889...45,150,555
Ensembl chr 2:45,081,889...45,149,897
G
Mapk1
mitogen activated protein kinase 1
ISO
PID
PID:200068
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:97,462,025...97,527,825
G
Mapk3
mitogen activated protein kinase 3
ISO
PID
PID:200068
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:190,797,185...190,803,411
G
Mapk8
mitogen-activated protein kinase 8
ISO
PID
PID:200068
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,645,198...8,728,427
G
Pik3ca
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
ISO
PID
PID:200068
NCBI chr 2:117,103,643...117,177,411
Ensembl chr 2:117,143,468...117,177,411
G
Pik3cb
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta
ISO
PID
PID:200068
NCBI chr 8:108,474,017...108,579,140
Ensembl chr 8:108,474,019...108,579,331
G
Pik3cd
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
ISO
PID
PID:200068
NCBI chr 5:165,377,994...165,426,620
Ensembl chr 5:165,377,994...165,403,968
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
ISO
PID
PID:200068
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:34,612,946...34,626,347
G
Pik3r2
phosphoinositide-3-kinase regulatory subunit 2
ISO
PID
PID:200068
NCBI chr16:18,699,389...18,708,045
Ensembl chr16:18,699,448...18,709,665
G
Pik3r3
phosphoinositide-3-kinase regulatory subunit 3
ISO
PID
PID:200068
NCBI chr 5:134,936,790...135,009,303
Ensembl chr 5:134,934,857...135,007,762
G
Ripk1
receptor interacting serine/threonine kinase 1
ISO
PID
PID:200068
NCBI chr17:31,044,983...31,077,167
Ensembl chr17:31,044,994...31,077,167
G
Smpd1
sphingomyelin phosphodiesterase 1
ISO
PID
PID:200068
NCBI chr 1:169,304,772...169,308,615
Ensembl chr 1:169,304,708...169,308,614
G
Tnfrsf10b
TNF receptor superfamily member 10b
IMP ISO
PID RGD
PMID:19934367 PMID:17403612 PMID:19961901
PID:200068, RGD:4142856 , RGD:4143170 , RGD:4143171
NCBI chr15:51,249,883...51,278,091
Ensembl chr15:51,250,112...51,278,082
G
Tnfrsf22
tumor necrosis factor receptor superfamily, member 22
ISO
PID
PID:200068
NCBI chr 1:208,269,844...208,285,823
Ensembl chr 1:208,258,836...208,289,832
G
Tnfsf10
TNF superfamily member 10
IMP ISO
PID RGD
PMID:19385008 PMID:17403612 PMID:19961901
PID:200068, RGD:2312745 , RGD:4143170 , RGD:4143171
NCBI chr 2:112,136,550...112,155,903
G
Tradd
TNFRSF1A-associated via death domain
ISO
PID
PID:200068
NCBI chr19:50,046,057...50,048,158
Ensembl chr19:50,046,061...50,052,550
G
Traf2
Tnf receptor-associated factor 2
ISO
PID
PID:200068
NCBI chr 3:28,740,098...28,764,752
Ensembl chr 3:28,740,098...28,764,691
G
Adam17
ADAM metallopeptidase domain 17
ISO
PID RGD
PMID:12655295
PID:200102, RGD:2292150
NCBI chr 6:46,601,583...46,663,690
Ensembl chr 6:46,601,583...46,649,344
G
Bag4
BAG cochaperone 4
ISO
PID RGD
PMID:12655295
PID:200102, RGD:2292150
NCBI chr16:72,991,407...73,008,620
Ensembl chr16:72,991,362...73,013,273
G
Birc2
baculoviral IAP repeat-containing 2
ISO
PID RGD
PMID:23085193
PID:200102, RGD:7800730
NCBI chr 8:13,253,697...13,273,672
Ensembl chr 8:13,253,706...13,271,911
G
Birc3
baculoviral IAP repeat-containing 3
ISO
PID RGD
PMID:23085193
PID:200102, RGD:7800730
NCBI chr 8:13,285,702...13,313,329
Ensembl chr 8:13,285,703...13,298,590
G
Casp8
caspase 8
ISO
PID
PID:200102
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:67,758,033...67,806,699
G
Cav1
caveolin 1
ISO
PID
PID:200102
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:46,600,738...46,639,740
G
Chuk
component of inhibitor of nuclear factor kappa B kinase complex
ISO
PID RGD
PMID:12655295
PID:200102, RGD:2292150
NCBI chr 1:252,908,748...252,944,273
Ensembl chr 1:252,908,749...252,944,273
G
Cyld
CYLD lysine 63 deubiquitinase
ISO
PID RGD
PMID:21119682 PMID:23312890
PID:200102, RGD:7800735 , RGD:7800734
NCBI chr19:34,487,491...34,547,311
Ensembl chr19:34,488,583...34,547,118
G
Fadd
Fas associated via death domain
ISO
PID RGD
PMID:12655295
PID:200102, RGD:2292150
NCBI chr 1:209,169,245...209,175,423
Ensembl chr 1:209,169,318...209,174,976
G
Ikbkb
inhibitor of nuclear factor kappa B kinase subunit beta
ISO
PID RGD
PMID:12655295
PID:200102, RGD:2292150
NCBI chr16:76,021,968...76,075,717
Ensembl chr16:76,022,008...76,081,911
G
Ikbkg
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
ISO
PID RGD
PMID:12655295
PID:200102, RGD:2292150
NCBI chr X:157,358,279...157,397,563
Ensembl chr X:157,367,639...157,392,757
G
Itch
itchy E3 ubiquitin protein ligase
ISO
RGD
PMID:23312890 PMID:21119682
RGD:7800734 , RGD:7800735
NCBI chr 3:164,102,490...164,193,932
Ensembl chr 3:164,105,812...164,193,932
G
Madd
MAP-kinase activating death domain
ISO
PID
PID:200102
NCBI chr 3:97,570,141...97,613,688
Ensembl chr 3:97,570,787...97,613,509
G
Map2k3
mitogen activated protein kinase kinase 3
ISO
PID
PID:200102
NCBI chr10:46,107,639...46,128,986
Ensembl chr10:46,106,548...46,129,004
G
Map2k7
mitogen activated protein kinase kinase 7
ISO
PID
PID:200102
NCBI chr12:7,389,032...7,398,377
Ensembl chr12:7,389,155...7,398,377
G
Map3k1
mitogen-activated protein kinase kinase kinase 1
ISO
PID
PID:200102
NCBI chr 2:45,081,889...45,150,555
Ensembl chr 2:45,081,889...45,149,897
G
Map3k3
mitogen activated protein kinase kinase kinase 3
ISO
PID
PID:200102
NCBI chr10:91,519,976...91,588,651
Ensembl chr10:91,519,888...91,588,651
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
ISO
PID
PID:200102
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:16,505,596...16,723,898
G
Map3k7
mitogen activated protein kinase kinase kinase 7
ISO
PID RGD
PMID:21135871
PID:200102, RGD:5490225
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:51,154,352...51,212,012
G
Map4k2
mitogen activated protein kinase kinase kinase kinase 2
ISO
PID
PID:200102
NCBI chr 1:213,074,360...213,090,042
Ensembl chr 1:213,074,377...213,096,987
G
Map4k3
mitogen-activated protein kinase kinase kinase kinase 3
ISO
PID
PID:200102
NCBI chr 6:20,029,246...20,198,583
Ensembl chr 6:20,029,397...20,198,583
G
Map4k4
mitogen-activated protein kinase kinase kinase kinase 4
ISO
PID
PID:200102
NCBI chr 9:49,696,573...49,822,353
Ensembl chr 9:49,696,700...49,822,353
G
Map4k5
mitogen-activated protein kinase kinase kinase kinase 5
ISO
PID
PID:200102
NCBI chr 6:94,020,079...94,112,943
Ensembl chr 6:94,020,079...94,112,943
G
Nfkb1
nuclear factor kappa B subunit 1
ISO
PID
PID:200102
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:226,689,745...226,783,088
G
Nrk
Nik related kinase
ISO
PID
PID:200102
NCBI chr X:107,159,154...107,256,417
Ensembl chr X:107,159,233...107,256,417
G
Nsmaf
neutral sphingomyelinase activation associated factor
ISO
PID
PID:200102
NCBI chr 5:24,315,319...24,378,346
Ensembl chr 5:24,315,319...24,375,355
G
Prkci
protein kinase C, iota
ISO
PID
PID:200102
NCBI chr 2:114,250,398...114,310,784
Ensembl chr 2:114,250,398...114,310,784
G
Prkcz
protein kinase C, zeta
ISO
PID
PID:200102
NCBI chr 5:171,101,774...171,212,694
Ensembl chr 5:171,101,774...171,212,674
G
Rack1
receptor for activated C kinase 1
ISO
PID
PID:200102
NCBI chr10:33,668,560...33,676,031
Ensembl chr10:33,670,270...33,675,948
G
Rbck1
RANBP2-type and C3HC4-type zinc finger containing 1
ISO
RGD
PMID:23085193
RGD:7800730
NCBI chr 3:161,249,389...161,266,321
Ensembl chr 3:161,249,390...161,266,032
G
Rela
RELA proto-oncogene, NF-kB subunit
ISO
PID
PID:200102
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:212,333,035...212,364,817
G
Rffl
ring finger and FYVE-like domain containing E3 ubiquitin protein ligase
ISO
PID
PID:200102
NCBI chr10:68,238,273...68,301,225
Ensembl chr10:68,238,273...68,321,902
G
Ripk1
receptor interacting serine/threonine kinase 1
ISO
PID RGD
PMID:12655295 PMID:23085193
PID:200102, RGD:2292150 , RGD:7800730
NCBI chr17:31,044,983...31,077,167
Ensembl chr17:31,044,994...31,077,167
G
Rnf11
ring finger protein 11
ISO
RGD
PMID:21119682 PMID:23312890
RGD:7800734 RGD:7800735
NCBI chr 5:129,441,071...129,471,799
Ensembl chr 5:129,442,309...129,463,538
G
Rnf31
ring finger protein 31
ISO
RGD
PMID:23085193
RGD:7800730
NCBI chr15:33,053,450...33,065,285
Ensembl chr15:33,053,607...33,065,284
G
Sharpin
SHANK-associated RH domain interactor
ISO
RGD
PMID:23085193
RGD:7800730
NCBI chr 7:109,951,336...109,955,552
Ensembl chr 7:109,950,345...109,955,552
G
Smpd1
sphingomyelin phosphodiesterase 1
ISO
PID
PID:200102
NCBI chr 1:169,304,772...169,308,615
Ensembl chr 1:169,304,708...169,308,614
G
Smpd2
sphingomyelin phosphodiesterase 2
ISO
PID
PID:200102
NCBI chr20:46,568,627...46,571,741
Ensembl chr20:46,568,629...46,571,741
G
Sqstm1
sequestosome 1
ISO
PID
PID:200102
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:35,026,598...35,037,750
G
Stat1
signal transducer and activator of transcription 1
ISO
PID
PID:200102
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:56,911,523...57,077,346
G
Tab1
TGF-beta activated kinase 1/MAP3K7 binding protein 1
ISO
PID RGD
PMID:21135871
PID:200102, RGD:5490225
NCBI chr 7:113,556,157...113,587,351
Ensembl chr 7:113,555,819...113,587,351
G
Tab2
TGF-beta activated kinase 1/MAP3K7 binding protein 2
ISO
PID RGD
PMID:21135871
PID:200102, RGD:5490225
NCBI chr 1:4,195,400...4,245,485
Ensembl chr 1:4,195,400...4,245,485
G
Tab3
TGF-beta activated kinase 1 (MAP3K7) binding protein 3
ISO
RGD
PMID:21135871
RGD:5490225
NCBI chr X:53,923,473...53,995,777
Ensembl chr X:53,923,492...53,995,610
G
Tax1bp1
Tax1 binding protein 1
ISO
RGD
PMID:23312890 PMID:21119682
RGD:7800734 , RGD:7800735
NCBI chr 4:83,152,549...83,208,463
Ensembl chr 4:83,110,062...83,209,657
G
Tnf
tumor necrosis factor
ISO
PID RGD
PMID:12655295
PID:200102, RGD:2292150
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,626,532...3,629,303
G
Tnfaip3
TNF alpha induced protein 3
ISO
RGD
PMID:23312890 PMID:21119682
RGD:7800734 , RGD:7800735
NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:15,528,921...15,543,979
G
Tnfrsf1a
TNF receptor superfamily member 1A
ISO IMP
PID RGD
PMID:12655295 PMID:20967881
PID:200102, RGD:2292150 , RGD:5130945
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:159,837,032...159,849,816
G
Tnfrsf1b
TNF receptor superfamily member 1B
ISO
PID RGD
PMID:12655295
PID:200102, RGD:2292150
NCBI chr 5:162,356,250...162,387,411
Ensembl chr 5:162,353,848...162,387,411
G
Tnik
TRAF2 and NCK interacting kinase
ISO
PID
PID:200102
NCBI chr 2:113,112,937...113,511,341
Ensembl chr 2:113,112,938...113,511,339
G
Tradd
TNFRSF1A-associated via death domain
ISO
PID RGD
PMID:12655295
PID:200102, RGD:2292150
NCBI chr19:50,046,057...50,048,158
Ensembl chr19:50,046,061...50,052,550
G
Traf1
TNF receptor-associated factor 1
ISO
PID
PID:200102
NCBI chr 3:38,607,707...38,639,641
Ensembl chr 3:38,619,506...38,636,264
G
Traf2
Tnf receptor-associated factor 2
ISO IMP
PID RGD
PMID:12655295 PMID:23085193 PMID:20967881
PID:200102, RGD:2292150 , RGD:7800730 , RGD:5130945
NCBI chr 3:28,740,098...28,764,752
Ensembl chr 3:28,740,098...28,764,691
G
Traf5
TNF receptor-associated factor 5
ISO
RGD
PMID:23085193
RGD:7800730
NCBI chr13:106,100,921...106,149,724
Ensembl chr13:106,103,291...106,149,707
G
Txn1
thioredoxin 1
ISO
PID
PID:200102
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:77,507,321...77,520,307
Pathway Gene Annotations
Disease Annotations Associated with Genes in the extrinsic apoptotic pathway
Casp3 abdominal aortic aneurysm , Acute Liver Failure , Acute Lung Injury , acute myocardial infarction , acute necrotizing pancreatitis , alcohol use disorder , Alzheimer's disease , amyotrophic lateral sclerosis , atherosclerosis , bacterial infectious disease , Binge Drinking , Brain Contusion , brain glioma , Brain Hypoxia-Ischemia , Brain Injuries , brain ischemia , breast cancer , breast carcinoma , bronchopulmonary dysplasia , Burns , calcinosis , cataract , Cerebral Hemorrhage , cervical cancer , Chemical and Drug Induced Liver Injury , chemical colitis , Chronic Hepatitis , chronic obstructive pulmonary disease , colon cancer , Colonic Neoplasms , congestive heart failure , Contrast-Induced Nephropathy , Copper-Overload Cirrhosis , cryptorchidism , diabetes mellitus , diabetic angiopathy , Diabetic Cardiomyopathies , Diabetic Nephropathies , diabetic neuropathy , diabetic retinopathy , dilated cardiomyopathy , Edema , endometritis , Endotoxemia , Experimental Autoimmune Encephalomyelitis , Experimental Autoimmune Myocarditis , Experimental Diabetes Mellitus , Experimental Mammary Neoplasms , Experimental Radiation Injuries , Fetal Growth Retardation , gastric ulcer , heart disease , heart valve disease , Hemorrhagic Shock , hepatocellular carcinoma , Huntington's disease , Hypercholesterolemia , hypertension , hyperthyroidism , hypertrophic cardiomyopathy , Hypoxia , impotence , Insulin Resistance , intermittent claudication , intestinal disease , Intestinal Reperfusion Injury , kidney disease , Kidney Reperfusion Injury , liver cirrhosis , Liver Reperfusion Injury , lung non-small cell carcinoma , Lung Reperfusion Injury , middle cerebral artery infarction , Mycoplasma Infections , myocardial infarction , Myocardial Reperfusion Injury , Neoplasm Metastasis , Nerve Degeneration , nervous system disease , osteoarthritis , Osteoarthritis, Experimental , Oxygen-Induced Retinopathy , pancreatitis , Parkinson's disease , Parkinsonism , Postoperative Cognitive Dysfunction , pre-malignant neoplasm , prostate cancer , Prostatic Neoplasms , renal cell carcinoma , Reperfusion Injury , retinal detachment , retinal disease , salivary gland disease , sciatic neuropathy , scrapie , Sepsis , severe acute respiratory syndrome , spermatic cord torsion , Spinal Cord Injuries , status epilepticus , stomach cancer , stroke , Subarachnoid Hemorrhage , Testis Reperfusion Injury , toxic encephalopathy , transient cerebral ischemia , transitional cell carcinoma , Transplant Rejection , traumatic brain injury , type 1 diabetes mellitus , type 2 diabetes mellitus , ulcerative colitis , ureteral obstruction , urinary bladder cancer , Ventricular Remodeling , Viral Myocarditis Casp7 acute myeloid leukemia , acute myocardial infarction , Alzheimer's disease , breast cancer , Breast Neoplasms , chemical colitis , colon cancer , Diabetic Nephropathies , endometritis , Endotoxemia , Experimental Liver Cirrhosis , Experimental Mammary Neoplasms , Kidney Reperfusion Injury , Lung Neoplasms , lung non-small cell carcinoma , Myocardial Reperfusion Injury , Osteoarthritis, Experimental , Retina Reperfusion Injury , retinitis pigmentosa , rheumatoid arthritis , sciatic neuropathy , Spinocerebellar Ataxias , transient cerebral ischemia , type 2 diabetes mellitus , ureteral obstruction , vitiligo Casp8 Acute Liver Failure , Acute Lung Injury , acute lymphoblastic leukemia , adenocarcinoma , alcohol use disorder , Alcohol-Related Disorders , allergic contact dermatitis , Alzheimer's disease , atopic dermatitis , autoimmune disease , autoimmune lymphoproliferative syndrome , autoimmune lymphoproliferative syndrome type 2B , bacterial infectious disease , Brain Contusion , Brain Hypoxia-Ischemia , Brain Injuries , breast cancer , Breast Cancer, Familial , Breast Neoplasms , bronchopulmonary dysplasia , Cerebral Hemorrhage , Chemical and Drug Induced Liver Injury , chronic obstructive pulmonary disease , Colorectal Neoplasms , contact dermatitis , Diabetic Cardiomyopathies , Diabetic Nephropathies , dilated cardiomyopathy , Edema , epilepsy , Esophageal Neoplasms , esophagus adenocarcinoma , esophagus squamous cell carcinoma , Experimental Autoimmune Encephalomyelitis , Experimental Autoimmune Myocarditis , Experimental Diabetes Mellitus , Experimental Mammary Neoplasms , Experimental Radiation Injuries , Familial Prostate Cancer , genetic disease , head and neck squamous cell carcinoma , heart disease , Hemorrhagic Shock , hepatocellular carcinoma , Huntington's disease , hyperglycemia , hypertension , Insulin Resistance , kidney disease , liver cirrhosis , Liver Reperfusion Injury , lung cancer , Lung Neoplasms , lung non-small cell carcinoma , melanoma , mitochondrial metabolism disease , Myocardial Reperfusion Injury , nephritis , Osteoarthritis, Experimental , pancreatic cancer , papillomavirus infectious disease , pre-malignant neoplasm , primary immunodeficiency disease , Reperfusion Injury , retinal detachment , sciatic neuropathy , Sepsis , Skin Neoplasms , status epilepticus , Stomach Neoplasms , transient cerebral ischemia , traumatic brain injury , type 1 diabetes mellitus , type 2 diabetes mellitus , Uterine Cervical Neoplasms , Viral Myocarditis Fas abdominal obesity-metabolic syndrome 1 , Acute Experimental Pancreatitis , acute kidney failure , Acute Liver Failure , Acute Lung Injury , acute lymphoblastic leukemia , acute myeloid leukemia , adult T-cell leukemia/lymphoma , alcohol-associated liver disease , alcoholic hepatitis , Alzheimer's disease , Animal Disease Models , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis , aplastic anemia , asthma , atherosclerosis , autoimmune disease , autoimmune hepatitis , autoimmune lymphoproliferative syndrome , Autoimmune Lymphoproliferative Syndrome, Type IA , autoimmune thrombocytopenic purpura , B-Cell Chronic Lymphocytic Leukemia , Barrett's esophagus , Behcet's disease , brain glioma , Brain Hypoxia-Ischemia , Brain Injuries , brain ischemia , breast cancer , breast carcinoma , cardiomyopathy , Cardiotoxicity , Cardiovascular Pregnancy Complications , cataract , Chemical and Drug Induced Liver Injury , Chest Trauma , chorioamnionitis , chronic conjunctivitis , chronic myeloid leukemia , chronic obstructive pulmonary disease , Chronic Uveitis , clonorchiasis , Colonic Neoplasms , congestive heart failure , corneal neovascularization , cryptorchidism , cystic fibrosis , dermatomyositis , diabetic angiopathy , Diabetic Nephropathies , diffuse large B-cell lymphoma , dilated cardiomyopathy , Disease Progression , endophthalmitis , Endotoxemia , Esophageal Neoplasms , esophagus adenocarcinoma , Experimental Allergic Asthma , Experimental Autoimmune Uveitis , Experimental Colitis , Experimental Diabetes Mellitus , Experimental Liver Cirrhosis , Experimental Liver Neoplasms , Experimental Mammary Neoplasms , Experimental Radiation Injuries , Experimental Seizures , Fetal Growth Retardation , gastric ulcer , genetic disease , glaucoma , glomerulonephritis , graft-versus-host disease , Graves' disease , Hashimoto Disease , HELLP syndrome , hematopoietic system disease , hepatitis B , hepatoblastoma , hepatocellular carcinoma , heroin dependence , high grade glioma , human immunodeficiency virus infectious disease , Huntington's disease , Hyperoxia , hypersplenism , Hypothermia , idiopathic pulmonary fibrosis , IgA glomerulonephritis , inclusion body myositis , infectious mononucleosis , Insulin Resistance , intrahepatic cholangiocarcinoma , Kashin-Beck Disease , kidney disease , Kidney Reperfusion Injury , left ventricular failure , leukocyte disease , limited scleroderma , liver disease , Liver Injury , Liver Reperfusion Injury , lung adenocarcinoma , Lung Injury , Lung Neoplasms , lupus nephritis , Lymphatic Metastasis , Lymphomatoid Papulosis , lymphoproliferative syndrome , macular degeneration , male infertility , melanoma , Metabolic Brain Diseases , metabolic dysfunction-associated steatotic liver disease , Metabolic Syndrome , mixed connective tissue disease , multiple sclerosis , multiple system atrophy , myasthenia gravis , myelodysplastic syndrome , Myocardial Reperfusion Injury , Nasal Polyps , nasal type extranodal NK/T-cell lymphoma , Necrosis , Neoplasm Metastasis , nephritis , ocular hypertension , ovarian cancer , Oxygen-Induced Retinopathy , Parkinson's disease , peripheral vascular disease , Plasmodium falciparum malaria , pre-eclampsia , pre-malignant neoplasm , primary biliary cholangitis , primary cutaneous T-cell non-Hodgkin lymphoma , primary immunodeficiency disease , prostate cancer , Prostatic Neoplasms , proteinuria , Puromycin Aminonucleoside Nephrosis , relapsing-remitting multiple sclerosis , renal cell carcinoma , Reperfusion Injury , retinal detachment , retinoblastoma , rheumatoid arthritis , sciatic neuropathy , seminoma , Sepsis , short-rib thoracic dysplasia 6 with or without polydactyly , Sjogren's syndrome , Spinal Cord Compression , Spinal Cord Injuries , splenic disease , Splenomegaly , squamous cell carcinoma , systemic lupus erythematosus , Taste Disorders , Temporomandibular Joint Osteoarthritis , Testicular Injury , transient cerebral ischemia , transitional cell carcinoma , type 1 diabetes mellitus , type 2 diabetes mellitus , ulcerative colitis , urinary bladder cancer , varicocele , Viral Bronchiolitis Faslg abdominal aortic aneurysm , Acute Experimental Pancreatitis , Acute Hepatitis , Acute Liver Failure , Acute Lung Injury , aplastic anemia , arteriosclerosis , atherosclerosis , autoimmune hepatitis , autoimmune lymphoproliferative syndrome , Autoimmune Lymphoproliferative Syndrome, Type IB , biliary tract benign neoplasm , brain glioma , brain ischemia , Breast Neoplasms , cardiomyopathy , Cardiotoxicity , carotid artery disease , carotid stenosis , cervix uteri carcinoma in situ , cholangiocarcinoma , chronic myeloid leukemia , chronic obstructive pulmonary disease , clonorchiasis , congestive heart failure , cystic fibrosis , diabetic angiopathy , Diabetic Nephropathies , dilated cardiomyopathy , drug allergy , Esophageal Neoplasms , Experimental Allergic Asthma , Experimental Arthritis , Experimental Autoimmune Encephalomyelitis , Experimental Diabetes Mellitus , familial combined hyperlipidemia , Fetal Growth Retardation , Gallbladder Neoplasms , gastric ulcer , graft-versus-host disease , HELLP syndrome , hepatitis , hepatitis B , hepatocellular carcinoma , Huntington's disease , Hypothermia , idiopathic pulmonary fibrosis , immunodeficiency 98 , infectious mononucleosis , Intestinal Reperfusion Injury , intrahepatic cholangiocarcinoma , invasive lobular carcinoma , Kidney Reperfusion Injury , leiomyoma , limited scleroderma , liver disease , Liver Injury , Liver Reperfusion Injury , lung cancer , Lung Injury , Lung Neoplasms , lung non-small cell carcinoma , melanoma , multiple myeloma , multiple sclerosis , myelodysplastic syndrome , Necrosis , Neoplasm Metastasis , Oxygen-Induced Retinopathy , pancreatic cancer , pancreatic ductal carcinoma , Parkinson's disease , pre-eclampsia , Prostatic Neoplasms , renal cell carcinoma , rheumatoid arthritis , seminoma , Sepsis , Spinal Cord Compression , substance-related disorder , testicular disease , transitional cell carcinoma , Transplant Rejection , type 1 diabetes mellitus , type 2 diabetes mellitus , ulcerative colitis , urinary bladder cancer , Uterine Cervical Neoplasms
abdominal aortic aneurysm Casp3 , Faslg abdominal obesity-metabolic syndrome 1 Fas Acute Experimental Pancreatitis Fas , Faslg Acute Hepatitis Faslg acute kidney failure Fas Acute Liver Failure Casp3 , Casp8 , Fas , Faslg Acute Lung Injury Casp3 , Casp8 , Fas , Faslg acute lymphoblastic leukemia Casp8 , Fas acute myeloid leukemia Casp7 , Fas acute myocardial infarction Casp3 , Casp7 acute necrotizing pancreatitis Casp3 adenocarcinoma Casp8 adult T-cell leukemia/lymphoma Fas alcohol use disorder Casp3 , Casp8 alcohol-associated liver disease Fas Alcohol-Related Disorders Casp8 alcoholic hepatitis Fas allergic contact dermatitis Casp8 Alzheimer's disease Casp3 , Casp7 , Casp8 , Fas amyotrophic lateral sclerosis Casp3 Animal Disease Models Fas Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Fas aplastic anemia Fas , Faslg arteriosclerosis Faslg asthma Fas atherosclerosis Casp3 , Fas , Faslg atopic dermatitis Casp8 autoimmune disease Casp8 , Fas autoimmune hepatitis Fas , Faslg autoimmune lymphoproliferative syndrome Casp8 , Fas , Faslg autoimmune lymphoproliferative syndrome type 2B Casp8 Autoimmune Lymphoproliferative Syndrome, Type IA Fas Autoimmune Lymphoproliferative Syndrome, Type IB Faslg autoimmune thrombocytopenic purpura Fas B-Cell Chronic Lymphocytic Leukemia Fas bacterial infectious disease Casp3 , Casp8 Barrett's esophagus Fas Behcet's disease Fas biliary tract benign neoplasm Faslg Binge Drinking Casp3 Brain Contusion Casp3 , Casp8 brain glioma Casp3 , Fas , Faslg Brain Hypoxia-Ischemia Casp3 , Casp8 , Fas Brain Injuries Casp3 , Casp8 , Fas brain ischemia Casp3 , Fas , Faslg breast cancer Casp3 , Casp7 , Casp8 , Fas Breast Cancer, Familial Casp8 breast carcinoma Casp3 , Fas Breast Neoplasms Casp7 , Casp8 , Faslg bronchopulmonary dysplasia Casp3 , Casp8 Burns Casp3 calcinosis Casp3 cardiomyopathy Fas , Faslg Cardiotoxicity Fas , Faslg Cardiovascular Pregnancy Complications Fas carotid artery disease Faslg carotid stenosis Faslg cataract Casp3 , Fas Cerebral Hemorrhage Casp3 , Casp8 cervical cancer Casp3 cervix uteri carcinoma in situ Faslg Chemical and Drug Induced Liver Injury Casp3 , Casp8 , Fas chemical colitis Casp3 , Casp7 Chest Trauma Fas cholangiocarcinoma Faslg chorioamnionitis Fas chronic conjunctivitis Fas Chronic Hepatitis Casp3 chronic myeloid leukemia Fas , Faslg chronic obstructive pulmonary disease Casp3 , Casp8 , Fas , Faslg Chronic Uveitis Fas clonorchiasis Fas , Faslg colon cancer Casp3 , Casp7 Colonic Neoplasms Casp3 , Fas Colorectal Neoplasms Casp8 congestive heart failure Casp3 , Fas , Faslg contact dermatitis Casp8 Contrast-Induced Nephropathy Casp3 Copper-Overload Cirrhosis Casp3 corneal neovascularization Fas cryptorchidism Casp3 , Fas cystic fibrosis Fas , Faslg dermatomyositis Fas diabetes mellitus Casp3 diabetic angiopathy Casp3 , Fas , Faslg Diabetic Cardiomyopathies Casp3 , Casp8 Diabetic Nephropathies Casp3 , Casp7 , Casp8 , Fas , Faslg diabetic neuropathy Casp3 diabetic retinopathy Casp3 diffuse large B-cell lymphoma Fas dilated cardiomyopathy Casp3 , Casp8 , Fas , Faslg Disease Progression Fas drug allergy Faslg Edema Casp3 , Casp8 endometritis Casp3 , Casp7 endophthalmitis Fas Endotoxemia Casp3 , Casp7 , Fas epilepsy Casp8 Esophageal Neoplasms Casp8 , Fas , Faslg esophagus adenocarcinoma Casp8 , Fas esophagus squamous cell carcinoma Casp8 Experimental Allergic Asthma Fas , Faslg Experimental Arthritis Faslg Experimental Autoimmune Encephalomyelitis Casp3 , Casp8 , Faslg Experimental Autoimmune Myocarditis Casp3 , Casp8 Experimental Autoimmune Uveitis Fas Experimental Colitis Fas Experimental Diabetes Mellitus Casp3 , Casp8 , Fas , Faslg Experimental Liver Cirrhosis Casp7 , Fas Experimental Liver Neoplasms Fas Experimental Mammary Neoplasms Casp3 , Casp7 , Casp8 , Fas Experimental Radiation Injuries Casp3 , Casp8 , Fas Experimental Seizures Fas familial combined hyperlipidemia Faslg Familial Prostate Cancer Casp8 Fetal Growth Retardation Casp3 , Fas , Faslg Gallbladder Neoplasms Faslg gastric ulcer Casp3 , Fas , Faslg genetic disease Casp8 , Fas glaucoma Fas glomerulonephritis Fas graft-versus-host disease Fas , Faslg Graves' disease Fas Hashimoto Disease Fas head and neck squamous cell carcinoma Casp8 heart disease Casp3 , Casp8 heart valve disease Casp3 HELLP syndrome Fas , Faslg hematopoietic system disease Fas Hemorrhagic Shock Casp3 , Casp8 hepatitis Faslg hepatitis B Fas , Faslg hepatoblastoma Fas hepatocellular carcinoma Casp3 , Casp8 , Fas , Faslg heroin dependence Fas high grade glioma Fas human immunodeficiency virus infectious disease Fas Huntington's disease Casp3 , Casp8 , Fas , Faslg Hypercholesterolemia Casp3 hyperglycemia Casp8 Hyperoxia Fas hypersplenism Fas hypertension Casp3 , Casp8 hyperthyroidism Casp3 hypertrophic cardiomyopathy Casp3 Hypothermia Fas , Faslg Hypoxia Casp3 idiopathic pulmonary fibrosis Fas , Faslg IgA glomerulonephritis Fas immunodeficiency 98 Faslg impotence Casp3 inclusion body myositis Fas infectious mononucleosis Fas , Faslg Insulin Resistance Casp3 , Casp8 , Fas intermittent claudication Casp3 intestinal disease Casp3 Intestinal Reperfusion Injury Casp3 , Faslg intrahepatic cholangiocarcinoma Fas , Faslg invasive lobular carcinoma Faslg Kashin-Beck Disease Fas kidney disease Casp3 , Casp8 , Fas Kidney Reperfusion Injury Casp3 , Casp7 , Fas , Faslg left ventricular failure Fas leiomyoma Faslg leukocyte disease Fas limited scleroderma Fas , Faslg liver cirrhosis Casp3 , Casp8 liver disease Fas , Faslg Liver Injury Fas , Faslg Liver Reperfusion Injury Casp3 , Casp8 , Fas , Faslg lung adenocarcinoma Fas lung cancer Casp8 , Faslg Lung Injury Fas , Faslg Lung Neoplasms Casp7 , Casp8 , Fas , Faslg lung non-small cell carcinoma Casp3 , Casp7 , Casp8 , Faslg Lung Reperfusion Injury Casp3 lupus nephritis Fas Lymphatic Metastasis Fas Lymphomatoid Papulosis Fas lymphoproliferative syndrome Fas macular degeneration Fas male infertility Fas melanoma Casp8 , Fas , Faslg Metabolic Brain Diseases Fas metabolic dysfunction-associated steatotic liver disease Fas Metabolic Syndrome Fas middle cerebral artery infarction Casp3 mitochondrial metabolism disease Casp8 mixed connective tissue disease Fas multiple myeloma Faslg multiple sclerosis Fas , Faslg multiple system atrophy Fas myasthenia gravis Fas Mycoplasma Infections Casp3 myelodysplastic syndrome Fas , Faslg myocardial infarction Casp3 Myocardial Reperfusion Injury Casp3 , Casp7 , Casp8 , Fas Nasal Polyps Fas nasal type extranodal NK/T-cell lymphoma Fas Necrosis Fas , Faslg Neoplasm Metastasis Casp3 , Fas , Faslg nephritis Casp8 , Fas Nerve Degeneration Casp3 nervous system disease Casp3 ocular hypertension Fas osteoarthritis Casp3 Osteoarthritis, Experimental Casp3 , Casp7 , Casp8 ovarian cancer Fas Oxygen-Induced Retinopathy Casp3 , Fas , Faslg pancreatic cancer Casp8 , Faslg pancreatic ductal carcinoma Faslg pancreatitis Casp3 papillomavirus infectious disease Casp8 Parkinson's disease Casp3 , Fas , Faslg Parkinsonism Casp3 peripheral vascular disease Fas Plasmodium falciparum malaria Fas Postoperative Cognitive Dysfunction Casp3 pre-eclampsia Fas , Faslg pre-malignant neoplasm Casp3 , Casp8 , Fas primary biliary cholangitis Fas primary cutaneous T-cell non-Hodgkin lymphoma Fas primary immunodeficiency disease Casp8 , Fas prostate cancer Casp3 , Fas Prostatic Neoplasms Casp3 , Fas , Faslg proteinuria Fas Puromycin Aminonucleoside Nephrosis Fas relapsing-remitting multiple sclerosis Fas renal cell carcinoma Casp3 , Fas , Faslg Reperfusion Injury Casp3 , Casp8 , Fas Retina Reperfusion Injury Casp7 retinal detachment Casp3 , Casp8 , Fas retinal disease Casp3 retinitis pigmentosa Casp7 retinoblastoma Fas rheumatoid arthritis Casp7 , Fas , Faslg salivary gland disease Casp3 sciatic neuropathy Casp3 , Casp7 , Casp8 , Fas scrapie Casp3 seminoma Fas , Faslg Sepsis Casp3 , Casp8 , Fas , Faslg severe acute respiratory syndrome Casp3 short-rib thoracic dysplasia 6 with or without polydactyly Fas Sjogren's syndrome Fas Skin Neoplasms Casp8 spermatic cord torsion Casp3 Spinal Cord Compression Fas , Faslg Spinal Cord Injuries Casp3 , Fas Spinocerebellar Ataxias Casp7 splenic disease Fas Splenomegaly Fas squamous cell carcinoma Fas status epilepticus Casp3 , Casp8 stomach cancer Casp3 Stomach Neoplasms Casp8 stroke Casp3 Subarachnoid Hemorrhage Casp3 substance-related disorder Faslg systemic lupus erythematosus Fas Taste Disorders Fas Temporomandibular Joint Osteoarthritis Fas testicular disease Faslg Testicular Injury Fas Testis Reperfusion Injury Casp3 toxic encephalopathy Casp3 transient cerebral ischemia Casp3 , Casp7 , Casp8 , Fas transitional cell carcinoma Casp3 , Fas , Faslg Transplant Rejection Casp3 , Faslg traumatic brain injury Casp3 , Casp8 type 1 diabetes mellitus Casp3 , Casp8 , Fas , Faslg type 2 diabetes mellitus Casp3 , Casp7 , Casp8 , Fas , Faslg ulcerative colitis Casp3 , Fas , Faslg ureteral obstruction Casp3 , Casp7 urinary bladder cancer Casp3 , Fas , Faslg Uterine Cervical Neoplasms Casp8 , Faslg varicocele Fas Ventricular Remodeling Casp3 Viral Bronchiolitis Fas Viral Myocarditis Casp3 , Casp8 vitiligo Casp7